Company: PSTV
Filing Date: 2025-06-09
Form Type: DRS
Source: 0000950123-25-005986
Chunk: 51

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-06-09
Form: DRS
Chunk 51
---
 Plus Therapeutics, Inc. Pursuant to 17 C.F.R. Section 200.83

|         |     |                                                                                                                                                                                                                       |     | Incorporated by Reference |     |             |     |         |     |             |
| Exhibit 
 Number  |     | Description                                                                                                                                                                                                           |     | Form                      |     | File Number |     | Exhibit |     | Filing Date |
| 10.19+  |     | Master Services Agreement, dated January 24, 2021, by and between Piramal Pharma Solutions, Inc. and Plus Therapeutics, Inc.                                                                                          |     | 10-K                      |     | 001-34275   |     |   10.24 |     | 02/22/2021  |
| 10.20

#  |     | Form of Indemnification Agreement.                                                                                                                                                                                    |     | 8-K                       |     | 001-34375   |     |    10.1 |     | 02/06/2020  |
| 10.21

#  |     | Form of Agreement for Acceleration and/or Severance.                                                                                                                                                                  |     | 10-K                      |     | 001-34375   |     |  10.113 |     | 03/11/2016  |
| 10.22   |     | Cancer Research Grant Contract, effective August 31, 2022, by and between the Cancer Prevention and Research Institute of Texas and Plus Therapeutics, Inc.                                                           |     | 8-K                       |     | 001-34375   |     |    10.1 |     | 09/22/2022  |
| 10.23   |     | Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto.                                                                |     | 8-K                       |     | 001-34375   |     |    10.1 |     | 03/03/2023  |
| 10.24

#  |     | Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as further amended and restated                                                                                                                                    |     | 8-K                       |     | 001-34375   |     |    10.1 |     | 04/20/2023  |
| 10.25   |     | Securities